Sarah Craig, (PhD Researcher)

Miss

Research Associate, School of Biomedical Sciences
Research Associate, Faculty Of Life & Health Sciences

PhoneUNKNOWN

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Sarah Craig is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

12 Similar Profiles

17 Citations
3 h-Index
8 Article

The methionine aminopeptidase 2 inhibitor, TNP-470, enhances the antidiabetic properties of sitagliptin in mice by upregulating xenin
Craig, S., Gault, V. A., Flatt, PR. & Irwin, N., 31 Jan 2021, In: Biochemical Pharmacology. 183, p. 1-10 10 p., 114355.
Research output: Contribution to journal › Article › peer-review
A GIP/xenin hybrid in combination with exendin-4 improves metabolic status in db/db diabetic mice and promotes enduring antidiabetic benefits in high fat fed mice
Craig, S., Perry, R., Vyavahare, S., Ng, M. T., Gault, V. A., Flatt, PR. & Irwin, N., 31 Jan 2020, In: Biochemical Pharmacology. 171, 113723.
Research output: Contribution to journal › Article › peer-review

Open Access
File
1 Citation (Scopus)

29 Downloads (Pure)
Individual and combined effects of GIP and xenin on differentiation, glucose uptake and lipolysis in 3T3-L1 adipocytes
English, A., Craig, S., Flatt, PR. & Irwin, N., 25 Oct 2020, In: Biological Chemistry. 401, 11, p. 1293-1303 11 p.
Research output: Contribution to journal › Article › peer-review
Ψ-xenin-6 enhances sitagliptin effectiveness, but does not improve glucose tolerance
Craig, S., Gault, V. A., Hamscher, G. & Irwin, N., 1 May 2020, In: Journal of Endrocrinology. 245, 2, p. 219-230 12 p.
Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus)
Antidiabetic effects and sustained metabolic benefits of sub-chronic co-administration of exendin-4/gastrin and xenin-8-Gln in high fat fed mice
Hasib, A., Khan, D., Craig, S., Gault, V. A., Flatt, PR. & Irwin, N., 15 Dec 2019, In: European Journal of Pharmacology. 865, 172733.
Research output: Contribution to journal › Article › peer-review

Open Access
File
14 Downloads (Pure)

Utilising the therapeutic potential of xenin and related molecules for diabetes and obesity
Author: Craig, S., May 2020
Supervisor: Irwin, N. (Supervisor) & Gault, V. (Supervisor)
Student thesis: Doctoral Thesis

File

The methionine aminopeptidase 2 inhibitor, TNP-470, enhances the antidiabetic properties of sitagliptin in mice by upregulating xenin

A GIP/xenin hybrid in combination with exendin-4 improves metabolic status in db/db diabetic mice and promotes enduring antidiabetic benefits in high fat fed mice

Individual and combined effects of GIP and xenin on differentiation, glucose uptake and lipolysis in 3T3-L1 adipocytes

Ψ-xenin-6 enhances sitagliptin effectiveness, but does not improve glucose tolerance

Antidiabetic effects and sustained metabolic benefits of sub-chronic co-administration of exendin-4/gastrin and xenin-8-Gln in high fat fed mice

Utilising the therapeutic potential of xenin and related molecules for diabetes and obesity